10.21203/ texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolizationHe An, Inderjeet Bhatia, Chuanmiao Xie,
Journal of Hepatology10.1016/s0168-8278(03)80399-920033899Timely repeated transarterial chemoembolization in patients with unresectable hepatocellular carcinoma who showed initial antitumoral effectC.-H. Park, W.-S. Lee, Y.-E. Joo, S.-K. Choi, J.-S. Rew, J.-K. Kim, S.-J. Kim,
Clinical Gastroenterology and Hepatology10.1016/j.cgh.2015.04.1552015137e119-e120Risk Prognostic Factors With Transarterial Chemoembolization for Patients of Medium-stage Hepatocellular CarcinomaChieh-Ling Yen,
10.21203/rs.2.21921/v12020Comparison of treatment response, survival profiles as well as safety profiles between CalliSpheres® microspheres transarterial chemoembolization and conventional transarterial chemoembolization in huge hepatocellular carcinomaXuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju,
10.21203/rs.2.21435/v12020Transarterial chemoembolization combined with apatinib for treatment of advanced hepatocellular carcinoma: analysis of survival and prognostic factorsZiyi Liu, Xuefeng Kan, Lijie Zhang, Joyman Makamure, Qing Li, Dan Zhao, Guofeng Zhou, Gansheng Feng, Chuansheng Zheng, Bin Liang,
Journal of Vascular and Interventional Radiology10.1016/j.jvir.2018.12.5992019303S224Abstract No. 518 Comprehensive analysis of treatment response and survival profiles in hepatocellular carcinoma patients: drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres versus conventional transarterial chemoembolizationC. Zheng, H. Xiang, C. Ma,
Translational Research10.1016/j.trsl.2012.01.01120121602146-152An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinomaDavid J. Pinato, Rohini Sharma,
PLOS ONE10.1371/journal.pone.01747692017123e0174769Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101Chao-Bin He, Xiao-Jun Lin
Journal of Vascular and Interventional Radiology10.1016/j.jvir.2018.01.3632018294S140-S1413:45 PM Abstract No. 327 Survival analysis and initial imaging response of conventional transarterial chemoembolization versus drug-eluting embolic transarterial chemoembolization for unresectable hepatocellular carcinomaN. Martinez, E. Bravo, T. Cermenati, B. Leon, J. Bravo, J. De Gracia, C. Moya, J. Weisz, P. Palavecino,
Journal of Hepatocellular Carcinoma10.2147/jhc.s3604212022Volume 9537-551Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial ChemoembolizationKun Ji, Hanlong Zhu, Wei Wu, Xin Li, Pengchao Zhan, Yang Shi, Junhui Sun, Zhen Li,